Vigabatrin is an antiepileptic drug used for treatment of infantile spasms. We present a female patient with infantile spasms in treatment with vigabatrin who developed ataxic movements. MRI demonstrated a symmetrical pattern of thalamic and globi pallidi diffusion restriction. While these image features have been widely described to be related to the use of vigabatrin, this case highlights the development of movement disorders in association with MRI signal changes. Awareness of the reversible nature of this condition is reassuring for the treating team and avoids unjustified studies.
RiikonenR. Recent advances in the pharmacotherapy of infantile spasms. CNS Drugs2014; 28: 279–290.
4.
DracopoulosAWidjajaERaybaudC. Vigabatrin-associated reversible MRI signal changes in patients with infantile spasms. Epilepsia2010; 51: 1297–1304.
5.
DillPDattaAWeberP. Are vigabatrin induced T2 hyperintensities in cranial MRI associated with acute encephalopathy and extrapyramidal symptoms?Eur J Paediatr Neurol2013; 17: 311–315.
6.
FongCOsborneJEdwardsS. An investigation into the relationship between vigabatrin, movement disorders, and brain magnetic resonance imaging abnormalities in children with infantile spasms. Dev Med Child Neurol2013; 55: 862–867.
7.
CohenJFisherRBrigellM. The potential for vigabatrin-induced intramyelinic edema in humans. Epilepsia2000; 41: 148–157.